Keywords

• Tretinoin
• 302-79-4
• C20H28O2

Quick Details

• ProName: Tretinoin
• CasNo: 302-79-4
• Molecular Formula: C20H28O2
• Appearance: powder
• Application: Pharmaceutical industry
• DeliveryTime: Stock
• PackAge: Bag / Bottle/Customize
• Port: Port of Tianjin
• ProductionCapacity: 5000 Kilogram/Month
• Purity: 99%
• Storage: In cool ,dry place
• Transportation: By sea, land, or air
• LimitNum: 1 Kilogram
• Impurity: 1%
• Assay: 99%
• Appearance: Yellow Powder
• Grade: Cosmetic&Pharmaceutical Grade

Superiority

Factory & Laboratory:
1. We have an excellent and professional research team that guarantees 99%
of our high-purity products.

2. Our factory has advanced chemical production equipment, advanced product research and
development technology team, in the purity of product quality has a professional
research team to strictly control. In the phoduction of products at the same time
committed toproduction innovation, improve product qualityat the same time,
reduce production costsincrease the interests of customers.

Details

Product Description

Tretinoin is the acid form of vitamin A and is also known as all-trans retinoic acid or ATRA. It is a drug commonly used to treat acne vulgaris and keratosis pilaris. It is available as a cream or gel It is also used to treat acute promyelocytic leukemia. It is also available as a generic.

Product picture

Function

Retinoic acid used in the treatment of acute promyelocytic leukemia, common acne, psoriasis, ichthyosis, lichen planus, erythematous furfuraceous rash, keratosis follicularis, squamous cell carcinoma and melanoma.

Application

Its success in treating acute promyelocytic leukemia was a major breakthrough in the treatment of this type of leukemia.It works in APL because the majority of cases involve a chromosomal translocation of chromosomes 15 and 17, which causes genetic fusion of the retinoic acid receptor gene to the promyelocytic leukemia  gene.

This fusion PML-RAR protein is responsible for preventing immature myeloid cells from differentiating into more mature cells. This block in differentiation is thought to cause leukemia.

ATRA acts on PML-RAR to lift this block, causing the immature promyelocytes to differentiate to normal mature blood cells thus decreasing promyelocytes.

Delivery

（1）≤50kg, Express delivery recommended, usually called as DDU service;

（2）≤500kg,Air shipping recommended, usually called as CIF service;

（3）>500kg, sea shipping recommended, usually called as FOB, CFR, or CIF service;

（4）For high value products, please select air shipping and express delivery for safety.

Packaging